Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swati Naphade

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Stem Cells (Dayton, Ohio)|September 5, 2014
Brief reports: Lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubesSwati Naphade, Jay Sharma, Héloïse P Gaide Chevronnay, et al.
Stem Cells (Dayton, Ohio)|May 8, 2025
Cerulenin Partially Corrects the Disrupted Developmental Transcriptomic Signature in Huntington's Disease Striatal Medium Spiny NeuronsCarlos Galicia Aguirre, Kizito-Tshitoko Tshilenge, Elena Battistoni, et al.
Aging Cell|November 6, 2020
FOXO3 targets are reprogrammed as Huntington's disease neural cells and striatal neurons face senescence with p16<sup>INK4a</sup> increaseJessica Voisin, Francesca Farina, Swati Naphade, et al.
Molecular & Cellular Proteomics : MCP|March 23, 2023
Proteomic Analysis of Huntington's Disease Medium Spiny Neurons Identifies Alterations in Lipid DropletsKizito-Tshitoko Tshilenge, Carlos Galicia Aguirre, Joanna Bons, et al.
Autophagy|May 24, 2021
Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levelsBarbara J Bailus, Stephen M Scheeler, Jesse Simons, et al.
Clinical and Translational Science|February 18, 2026
Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635Geraldine Gontier, Grace Kim, Chao Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2025
Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulatorTyler P Molitor, Genki Hayashi, Mei-Yao Lin, et al.
Acta Neuropathologica|July 10, 2020
Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregatesPaula García-Huerta, Paulina Troncoso-Escudero, Di Wu, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Stem Cells (Dayton, Ohio)|September 5, 2014
Brief reports: Lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubesSwati Naphade, Jay Sharma, Héloïse P Gaide Chevronnay, et al.
Stem Cells (Dayton, Ohio)|May 8, 2025
Cerulenin Partially Corrects the Disrupted Developmental Transcriptomic Signature in Huntington's Disease Striatal Medium Spiny NeuronsCarlos Galicia Aguirre, Kizito-Tshitoko Tshilenge, Elena Battistoni, et al.
Aging Cell|November 6, 2020
FOXO3 targets are reprogrammed as Huntington's disease neural cells and striatal neurons face senescence with p16<sup>INK4a</sup> increaseJessica Voisin, Francesca Farina, Swati Naphade, et al.
Molecular & Cellular Proteomics : MCP|March 23, 2023
Proteomic Analysis of Huntington's Disease Medium Spiny Neurons Identifies Alterations in Lipid DropletsKizito-Tshitoko Tshilenge, Carlos Galicia Aguirre, Joanna Bons, et al.
Autophagy|May 24, 2021
Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levelsBarbara J Bailus, Stephen M Scheeler, Jesse Simons, et al.
Clinical and Translational Science|February 18, 2026
Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635Geraldine Gontier, Grace Kim, Chao Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2025
Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulatorTyler P Molitor, Genki Hayashi, Mei-Yao Lin, et al.
Acta Neuropathologica|July 10, 2020
Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregatesPaula García-Huerta, Paulina Troncoso-Escudero, Di Wu, et al.
Pageof 2